Bishnoi Dental Care has conducted 1,000+ outreach camps in Rajasthan, screening 40,000 rural patients and improving dental ...
BioArctic's AB (publ) (STOCKHOLM: BIOA B) partner Eisai announced today that they will present the latest findings on lecanemab at the 2026 International ...
Opinion
The New Times on MSNOpinion

Oral health is not a luxury, it is a necessity

Many people do not think about their oral health until they feel pain. They only visit the dentist when a tooth is hurting badly. But most of the time, when pain starts, the problem is already serious ...
A study out of the University of North Carolina at Chapel Hill has unveiled new insights into the inflammatory processes behind periodontitis, a common and debilitating gum disease. Research conducted ...
The field of oral and craniomaxillofacial health is facing rapid transformation as it grapples with longstanding clinical challenges such as congenital ...
Celebrated globally on 20 March and endorsed by the FDI World Dental Federation, World Oral Health Day encourages ...
Recognizing this, Preferred Dental is moving toward a more diagnostic and preventative model of care that views the mouth as a mirror of the body’s internal environment. By identifying early markers ...
FDA approval introduces first-in-class, once-daily oral TYK2 inhibition for active psoriatic arthritis, expanding deucravacitinib beyond its 2022 plaque psoriasis indication. POETYK PsA-1 and PsA-2 ...
Regulatory expansion positions deucravacitinib 6 mg once daily as a first-in-class oral TYK2 option for active PsA, complementing its prior plaque psoriasis indication. POETYK PsA-1 showed significant ...
Roche's shares dropped more than 7% at one stage on Monday, their biggest ​decline in nearly a year, after the Swiss ...
One theory: Certain bacteria may produce carcinogens, which are cancer-causing substances. His research has linked certain mouth microbes to an increased risk for cancer in the colon, esophagus and ...
This week in Africa: a potential breakthrough in the fight against sleeping sickness with a single-dose oral treatment, alongside a $1.2 billion health agreement between the DRC and the United States.